In the news
Read the latest about myTomorrows
October 10, 2025
myTomorrows' COO Vanessa Lemarié Named in Sifted's Top 100 Woman in Tech Europe
The annual list, curated by Sifted (backed by the Financial Times) shines a spotlight on founders, investors, operators, and ecosystem builders whose work is driving real change.
September 18, 2025
myTomorrows Announces a New Solution to Support Trial Site Clinical Research Teams Through its AI-Powered Platform
The referral management tool enables research teams to share and update custom trial information in real time, unify fragmented referral processes, and accelerate pre-screening.
September 18, 2025
myTomorrows Expands AI Capabilities to Streamline Patient Recruitment and Communication in Clinical Trials
The new solution aims to improve workflows at research sites by enabling centralized referral management, providing real-time updates on trials, and facilitating better communication with physicians.
September 9, 2025
Insights on How Sponsors Can Modernize Tools to Support Physicians
myTomorrows Senior Community Development Manager Adrienne Rivard, discusses how fragmented systems and outdated trial registries act as barriers to patient referrals - and the need for unified real-time referral management.
September 5, 2025
Over 275 Duchenne Patients Enrolled in Pre-Approval Treatment Programs with myTomorrows
myTomorrows celebrates referring more than 600 Duchenne Muscular Dystrophy patients to clinical trials and expanded access programs with its precision matching AI platform, with nearly 300 enrollments.
August 27, 2025
A DMD Case Study on Regulatory Innovation and Treatment Advancement
myTomorrows COO Vanessa Lemarié contributes insights to International Clinical Trials on how regulatory innovation is improving treatment access for Duchenne Muscular Dystrophy (DMD).
July 18, 2025
Physicians Cite AI as Key to Improving Clinical Trial Matching and Access
myTomorrows launches new data survey. Findings identify physician perceived value of AI in the trial access and discovery process, but more needs to be done to adoption.
July 18, 2025
Navigating Clinical Trials: Physicians Face Major Hurdles in Accessing Innovative Treatments
New myTomorrows’ research identifies physician related challenges in the clinical trial discovery and access process, highlighting the how technology and AI can help.
July 17, 2025
Nearly 75% of Physicians Say Time-Consuming Clinical Trial Searches Delay Patient Treatment
myTomorrows launches new data report, based on survey of U.S. based healthcare professionals, entitled ‘Searching for solutions: How physicians navigate trial access and technology’.
June 24, 2025
How Biomarkers are Shaping Parkinson’s Diagnosis and Clinical Trials
Romina Dibra, Senior Site Manager at myTomorrows assesses how the discovery of reliable biomarkers for Parkinson’s marks a turning point in the fight against this condition.
May 28, 2025
myTomorrows Unveils New SaaS Platform for Expanded Access Programs
Health tech company myTomorrows launches a dedicated platform to help BioPharma companies compliantly manage expanded access programs with efficiency.
May 27, 2025
The Future of Drug Discovery: AI-Powered Predictions and Virtual Patient Models
Michel van Haten, MD, explores how AI is reshaping the future of clinical research and development via personalized treatment pathways and intuitive data modelling.
May 23, 2025
AI Lowers Real-World Barriers to Trial Participation
Michel van Harten, MD, analyses the use of AI to overcome real-world constraints in accessing clinical trials.
May 22, 2025
AI’s Role in Solving Clinical Trial Diversity and Access Challenges
Michel van Harten, MD, examines how AI-powered platforms, such as myTomorrows’, can help to promote equity in patient access to trials.
May 21, 2025
Bridging Innovation and Trust in Artificial Intelligence
Michel van Harten, MD, discusses the importance of transparency and trust in the adoption of AI in clinical trials.
May 20, 2025
myTomorrows Surpasses 15,000 Patient Matches Through AI and Personalized Services
myTomorrows announces a major milestone in matching over 15,000 patients to pre-approval treatments worldwide.
May 1, 2025
myTomorrows Named Finalist in 2025 Fierce DEI Awards
myTomorrows has been shortlisted for the Inclusive Patient Experience Design category of the Fierce DEI Awards, recognizing advancements in diversity, equity, and inclusion in clinical trial access and recruitment.
April 16, 2025
myTomorrows and Scout Partner to Provide Cross-Border Trial Recruitment
Scout and myTomorrows announce an exciting partnership designed to support international trial patient access.
April 15, 2025
myTomorrows and Scout Clinical Partner for Cross-Border Clinical Trial Recruitment
myTomorrows and Scout partner to enhance global cross-border patient recruitment with AI-powered support and patient concierge services.
March 26, 2025
Artificial Intelligence: Addressing Clinical Trials’ Greatest Challenges
CEO Michel van Harten MD, explores how myTomorrows uses AI to improve clinical trial matching, improve patient access, and accelerate recruitment.
February 26, 2025
Heath tech firm partners with UK medical recordkeeper to match patients with clinical trials
Clinical trial matchmaker myTomorrows has struck up a partnership with personal health recordkeeper Patients Know Best (PKB) so that UK participants can search for possible trials to join.
February 25, 2025
Partnership will support patients to find pre-approval treatments
myTomorrows and Patients Know Best (PKB) have partnered to enable UK patients with unmet medical needs to conduct more efficient searches for further treatment options.
February 17, 2025
Technological Advancements in ALS Management
Romina Dibra MD, expert at healthcare technology company myTomorrows, has shared her insight into the most recent technological advancements in ALS Management and how they aim to enhance early diagnosis, significantly improve quality of life and provide more effective, personalized treatments.
February 14, 2025
Emerging treatments for Type 1 Diabetes
Angela Sarmiento Betancourt, MD. at myTomorrows, shares her insights into current strategies and patient-centric research advancements for the treatment of type 1 diabetes.
February 7, 2025
myTomorrows Launches AI Platform for Precision Trials
With the goal of streamlining industry-wide clinical trial recruitment and improving patient outcomes, myTomorrows unveils its next major AI-powered technological advancement.
February 7, 2025
Physicians and BioPharma should improve accessibility of cancer trials.
Michel van Harten, MD, discusses the importance of accessibility within oncological clinical trials which pave the way for better patient outcomes and accelerate critical cancer treatments.
February 6, 2025
myTomorrows Introduces Next-Generation AI Platform for Precision Matching
Designed to streamline clinical trial recruitment, the platform supercharges how physicians search, pre-screen, and refer patients — helping trial sponsors accelerate enrollment, enhance diversity, and optimize operations.
February 3, 2025
Building Trust in Investigational Treatments
Michel van Harten, MD, discusses how physicians and BioPharma companies and patient advocacy groups can address trust challenges by actively engaging with patient communities to empower them to participate in shaping the future of medicine.
February 3, 2025
AI in Oncology: The Bridge Between the Patient and the Practice.
Danny den Hamer, myTomorrows Product Manager discussed the use of AI to improve oncology care and how it can support finding the right clinical trials for patients.
January 20, 2025
A guide to understanding cervical cancer and spotting the signs early
Angela Sarmiento Betancourt MD, Medical Affairs Manager shares her insights on the key red flags of cervical cancer, including some common symptoms and how to spot them early.
January 15, 2025
Increasing Participation in Muscular Dystrophy Clinical Trials
Michel van Harten, MD, discusses how by addressing structural barriers and expanding awareness can help boost participation in clinical trials, potentially advance the development and approval of new drugs, and inform accessibility for patients with rare diseases.
January 13, 2025
2025 predictions: Which trends are set to shape the biotech industry this year?
Michel van Harten, MD, contributes to the discussion noting the emerging importance of decentralized trial designs, enhanced community engagement and the important role of patient advocacy groups.
January 3, 2025
Navigating the Future of Clinical Trial Recruitment with Jytte van Huijstee
In this discussion, Jytte van Huijstee, Director of Clinical Trial Operations at myTomorrows, shares insights on technology’s role in clinical trials, addressing recruitment gaps, and fostering diversity.
December 17, 2024
myTomorrows adds ISRCTN to clinical trial search
The myTomorrows search function now includes the ISRCTN while its platform has added AI eligibility checking for clinical trials.
December 5, 2024
myTomorrows expands into APAC to Improve access to Clinical Trials and Programs across the region
Drawing on its extensive experience connecting physicians and patients to different treatment options, myTomorrows will address challenges in accessing treatments in development across the growing and diverse APAC market.
December 4, 2024
Health tech company myTomorrows cuts ribbon at India operations hub, looks to expand clinical trial access in Asia
The primary goal of the hub is to build an operational foundation that can serve growing markets in the region and help patients.
November 27, 2024
Enhancing Clinical Trial Enrollment with Michel van Harten, MD.
In this podcast Michel van Harten, MD speaks about creating better information systems for physicians and patients & how shared decision-making can improve drug development and more.
October 24, 2024
How to Enhance DEI in Clinical Trials
In this article, Michel van Harten MD, discusses the profound consequences that equitable and ethical care can have on patient outcomes.
September 30, 2024
myTomorrows and CureLGMD2i Partnership to Improve Access to Clinical Trials for Limb Girdle Muscular Dystrophy.
Kelly Brazzo, founder and CEO of CureLGMD2i Foundation, and Dennis Akkaya, chief Commercial Officer at MyTomorrows, share insights on a new partnership that aims to ease accessibility to drug development trials for patients with LGMD.
September 25, 2024
How to advance diversity, equity and inclusion in clinical trial recruitment.
myTomorrows CEO Michel van Harten, MD, discusses how Infusing DEI considerations into clinical trial recruitment and enrollment will prove crucial for drug discovery and novel therapies.
September 9, 2024
Treating the age of misinformation
CEO of myTomorrows, Michel van Harten M.D. discusses the dangerous implications of medical misinformation, not only for patients but also for healthcare professionals and the wider BioPharma industry.
September 4, 2024
myTomorrows and the CureLGMD2i Foundation Partner to Ease Access to Clinical Trials for Patients with Limb Girdle Muscular Dystrophy Type 2I/R9.
Under a new partnership, CureLGMD2i will leverage myTomorrows' extensive search engine of ongoing clinical trials to provide patients, caregivers, and healthcare professionals with up-to-date, accessible information about pre-approval treatments that may be relevant to them.
September 3, 2024
New collaboration aims to streamline trial access for patients.
Global health technology company myTomorrows announce a new partnership with Pancreatic Cancer Europe (PCE), a multi-stakeholder platform dedicated to improving care for pancreatic cancer patients.
August 27, 2024
myTomorrows and Pancreatic Cancer Europe Partner to Support Pancreatic Cancer Patients in Accessing Clinical Trials.
Pancreatic cancer is notoriously challenging to treat, with a life expectancy of only 6-12 months at the time of diagnosis and a 5-year survival rate of just 10%. This partnership aims to enhance access to clinical trials for people suffering with pancreatic cancer by leveraging myTomorrows’ extensive search engine of ongoing trials.
July 1, 2024
Senior level moves within drug discovery
Marshall Van Beurden, joins myTomorrows as Chief Technology Officer.. Van Beurden previously was the Managing Director for the Amazon Web Services (AWS) development center in the Netherlands and led the Enterprise Engineering team at Miro.
June 10, 2024
Physician And myTomorrows CEO Discusses FDA’s New Program To Advance Clinical Trial Diversity
The US FDA recently announced a new initiative aimed at improving access to cancer trials among traditionally underserved populations. myTomorrows CEO Michel van Harten talked to Medtech Insight about how the agency’s plan might reshape the landscape of clinical trials going forward.
May 16, 2024
Types of clinical trial designs: the essentials
Jytte van Huijstee, Director of Clinical Trial Operations at myTomorrows, highlights the shift towards more patient-centric clinical trials. This approach focuses on designing trials that are more considerate of the patient’s needs and convenience, which can enhance patient recruitment and retention.
April 9, 2024
New partnership to improve access to brain tumour clinical trials
A new collaboration announced today will help provide brain tumour patients and physicians with accurate information about clinical trials in a bid to improve patient access.
April 9, 2024
myTomorrows and brainstrust partner to support patients living with brain cancer
Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis. myTomorrows has announced a new partnership with a UK-based charity, brainstrust, to support individuals living with brain cancer.
April 5, 2024
myTomorrows and brainstrust partner to support patients living with brain cancer
Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis. myTomorrows has announced a new partnership with a UK-based charity, brainstrust, to support individuals living with brain cancer.
April 4, 2024
myTomorrows partners with UK brainstrust to improve access to clinical trials
myTomorrows and UK brainstrust plans to increase patient recruitment in brain tumour clinical trials by increasing awareness.
April 4, 2024
myTomorrows Partners with brainstrust to Support Brain Cancer Patients in Accessing Clinical Trials
myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with brainstrust, a UK-based charity that helps people living with a brain tumor reach their potential and thrive.
April 1, 2024
Search, Click, Enroll? What Clinical Trials Can Learn from E-commerce
Certain features, commonplace on most e-commerce platforms, can help transform clinical trial search databases.
March 15, 2024
ALS body takes digital approach to clinical trials access
A non-profit organisation representing the amyotrophic lateral sclerosis (ALS) community in the US is taking a digital approach to connecting patients with suitable clinical trials.
March 14, 2024
myTomorrows Partners with The ALS Association to Support ALS Patients in Accessing Clinical Trials
Partnership with leading US-based ALS patient advocacy group furthers myTomorrows' mission of ensuring that patients confronting life-threatening diseases are aware of all possible treatment options
December 6, 2023
Using AI for patient pre-screening
CEO Michel van Harten speaks with Clinical Trial Vanguard about myTomorrows’ innovative use of AI in physician-led clinical trial screening.
November 29, 2023
8 promising Amsterdam-based medtech startup to watch
"I started myTomorrows in 2012 after losing my father to an aggressive form of lung cancer. As a physician and founder of several biotech companies, I thought I could help him find and access a treatment in development. But I was surprised at how complicated and slow the process was. I decided this had to change, so I dedicated myself to creating an easier and faster way for patients to access treatments in development.
We have grown a lot since then, and our team of experts has helped patients in over 60 countries. But our guiding principle remains the same: We believe every patient should have access to all possible treatment options. We are here for you, so let us know how we can help."
September 13, 2023
Congenica goes Dutch to help cancer patients worldwide
myTomorrows teams up with digital health innovator Congenica, highlighting tech’s role in the future of healthcare.
July 25, 2023
Navigating the maze of clinical trial access
myTomorrows shares insights on discovering clinical trials for cancer.
June 28, 2023
Using AI to Match Patients With Clinical Trials in Minutes
myTomorrows’ CEO explores the power of AI for matching patients with the clinical trials right for them
April 27, 2023
Clinical trial matchmaker myTomorrows launches AI-backed recruiting tool
Fierce Biotech shares launch of myTomorrows exciting new AI-backed patient pre-screening tool.
April 26, 2023
AI Powered Service Seeks to Connect Patients to Trials, Expanded Access Programs
The global Health technology company myTomorrows said it launched the beta version of TrialSearch AI, a first-of-its-kind artificial intelligence tool to broaden physician insights into clinical trials and expanded access programs in the myTomorrows’ curated database.
